{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:12:03Z","timestamp":1790788323016,"version":"4.1.0"},"reference-count":134,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"am","delay-in-days":338,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.metabol.2021.154841","type":"journal-article","created":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T22:50:11Z","timestamp":1627599011000},"page":"154841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Hearing loss in inherited metabolic disorders: A systematic review"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3034-7908","authenticated-orcid":false,"given":"T.-T.","family":"Trinh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Blasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Maillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Bakhos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9462","key":"10.1016\/j.metabol.2021.154841_bb0005","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0140-6736(05)71047-3","article-title":"Sensorineural hearing loss in children","volume":"365","author":"Smith","year":"2005","journal-title":"Lancet."},{"key":"10.1016\/j.metabol.2021.154841_bb0010","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/bs.acc.2015.12.001","article-title":"Inborn errors of metabolism","volume":"73","author":"Ezgu","year":"2016","journal-title":"Adv Clin Chem"},{"issue":"2","key":"10.1016\/j.metabol.2021.154841_bb0015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.pcl.2017.11.002","article-title":"Inborn errors of metabolism overview: pathophysiology, manifestations, evaluation, and management","volume":"65","author":"Saudubray","year":"2018","journal-title":"Pediatr Clin North Am"},{"issue":"9","key":"10.1016\/j.metabol.2021.154841_bb0020","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.arcped.2012.06.002","article-title":"Maladies h\u00e9r\u00e9ditaires du m\u00e9tabolisme: signes ant\u00e9natals et diagnostic biologique [prenatal symptoms and diagnosis of inherited metabolic diseases]","volume":"19","author":"Brassier","year":"2012","journal-title":"Arch Pediatr"},{"issue":"24","key":"10.1016\/j.metabol.2021.154841_bb0025","doi-asserted-by":"crossref","first-page":"467","DOI":"10.21037\/atm.2018.11.36","article-title":"Inborn errors of metabolism in the 21st century: past to present","volume":"6","author":"Arnold","year":"2018","journal-title":"Ann Transl Med"},{"issue":"2","key":"10.1016\/j.metabol.2021.154841_bb0030","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.pcl.2017.11.013","article-title":"Newborn screening: history, current status, and future directions","volume":"65","author":"El-Hattab","year":"2018","journal-title":"Pediatr Clin North Am"},{"issue":"1","key":"10.1016\/j.metabol.2021.154841_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147793","article-title":"Visual cross-modal re-organization in children with cochlear implants","volume":"11","author":"Campbell","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.metabol.2021.154841_bb0040","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1067\/mpd.2002.121938","article-title":"Hearing loss is a common feature of symptomatic children with profound biotinidase deficiency","volume":"140","author":"Wolf","year":"2002","journal-title":"J Pediatr"},{"issue":"1\u20132","key":"10.1016\/j.metabol.2021.154841_bb0045","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0378-5955(02)00609-3","article-title":"Localization of biotinidase in the brain: implications for its role in hearing loss in biotinidase deficiency","volume":"173","author":"Heller","year":"2002","journal-title":"Hear Res"},{"key":"10.1016\/j.metabol.2021.154841_bb0050","first-page":"33","article-title":"Outcomes of oral biotin treatment in patients with biotinidase deficiency - twenty years follow-up","volume":"5","author":"Szyma\u0144ska","year":"2015","journal-title":"Mol Genet Metab Rep"},{"issue":"6","key":"10.1016\/j.metabol.2021.154841_bb0055","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/ana.25110","article-title":"Progressive deafness-dystonia due to SERAC1 mutations: a study of 67 cases","volume":"82","author":"Maas","year":"2017","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.metabol.2021.154841_bb0060","first-page":"56","article-title":"Increased reactive oxygen species (ROS) production and low catalase level in fibroblasts of a girl with MEGDEL association (Leigh syndrome, deafness, 3-methylglutaconic aciduria)","volume":"49","author":"Karkucinska-Wieckowska","year":"2011","journal-title":"Folia Neuropathol"},{"issue":"1","key":"10.1016\/j.metabol.2021.154841_bb0065","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ymgme.2006.01.013","article-title":"Association of 3-methylglutaconic aciduria with sensori-neural deafness, encephalopathy, and Leigh-like syndrome (MEGDEL association) in four patients with a disorder of the oxidative phosphorylation","volume":"88","author":"Wortmann","year":"2006","journal-title":"Mol Genet Metab"},{"issue":"4","key":"10.1016\/j.metabol.2021.154841_bb0070","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10545-005-0479-x","article-title":"Congenital cataract, muscular hypotonia, developmental delay and sensorineural hearing loss associated with a defect in copper metabolism","volume":"28","author":"Horv\u00e1th","year":"2005","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"10.1016\/j.metabol.2021.154841_bb0075","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ajhg.2011.11.030","article-title":"Mutations in SLC33A1 cause a lethal autosomal-recessive disorder with congenital cataracts, hearing loss, and low serum copper and ceruloplasmin","volume":"90","author":"Huppke","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.metabol.2021.154841_bb0080","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s11011-016-9854-6","article-title":"Huppke-Brendel syndrome in a seven months old boy with a novel 2-bp deletion in SLC33A1","volume":"31","author":"Chiplunkar","year":"2016","journal-title":"Metab Brain Dis"},{"issue":"1","key":"10.1016\/j.metabol.2021.154841_bb0085","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10545-010-9242-z","article-title":"Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment","volume":"34","author":"Bosch","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.metabol.2021.154841_bb0090","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1750-1172-7-83","article-title":"The Brown-Vialetto-Van Laere and Fazio Londe syndrome revisited: natural history, genetics, treatment and future perspectives","volume":"7","author":"Bosch","year":"2012","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10.1016\/j.metabol.2021.154841_bb0095","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/mus.24224","article-title":"Mutations in riboflavin transporter present with severe sensory loss and deafness in childhood","volume":"50","author":"Srour","year":"2014","journal-title":"Muscle Nerve"},{"issue":"9","key":"10.1016\/j.metabol.2021.154841_bb0100","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1097\/MAO.0000000000000572","article-title":"Neurotologic and functional MRI findings in a patient with bilateral profound deafness having Brown-Vialetto-Van Leare syndrome","volume":"35","author":"Salmina","year":"2014","journal-title":"Otol Neurotol"},{"issue":"5","key":"10.1016\/j.metabol.2021.154841_bb0105","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1017\/S0022215114003375","article-title":"Auditory neuropathy spectrum disorder with Brown-Vialetto-Van Laere syndrome: challenges in hearing rehabilitation","volume":"129","author":"Chandran","year":"2015","journal-title":"J Laryngol Otol"},{"issue":"1","key":"10.1016\/j.metabol.2021.154841_bb0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/14670100.2018.1534035","article-title":"Cochlear implantation in children with auditory neuropathy: lessons from Brown-Vialetto-Van Laere syndrome","volume":"20","author":"Anderson","year":"2019","journal-title":"Cochlear Implants Int"},{"issue":"2","key":"10.1016\/j.metabol.2021.154841_bb0115","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/archderm.1974.01630080059017","article-title":"Ichthyosiform dermatosis with systemic lipidosis","volume":"110","author":"Dorfman","year":"1974","journal-title":"Arch Dermatol"},{"issue":"5957","key":"10.1016\/j.metabol.2021.154841_bb0120","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/bmj.1.5957.553","article-title":"Neutral-lipid storage disease: a new disorder of lipid metabolism","volume":"1","author":"Chanarin","year":"1975","journal-title":"Br Med J"},{"issue":"4","key":"10.1016\/j.metabol.2021.154841_bb0125","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/ajmg.1320200417","article-title":"Ichthyosis and neutral lipid storage disease","volume":"20","author":"Williams","year":"1985","journal-title":"Am J Med Genet"},{"issue":"1","key":"10.1016\/j.metabol.2021.154841_bb0130","first-page":"105","article-title":"Chanarin-Dorfman syndrome","volume":"30","author":"Kalyon","year":"2019","journal-title":"Turk J Gastroenterol Off J Turk Soc Gastroenterol"},{"issue":"2","key":"10.1016\/j.metabol.2021.154841_bb0135","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00198-018-4691-6","article-title":"Neurological symptoms in Hypophosphatasia","volume":"30","author":"Colazo","year":"2019","journal-title":"Osteoporos Int"},{"issue":"8289","key":"10.1016\/j.metabol.2021.154841_bb0140","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0140-6736(82)91690-7","article-title":"An X-linked syndrome characterised by hyperuricaemia, deafness, and neurodevelopmental abnormalities","volume":"320","author":"Simmonds","year":"1982","journal-title":"The Lancet"},{"issue":"2","key":"10.1016\/j.metabol.2021.154841_bb0145","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1055\/s-2008-1052552","article-title":"An inborn error of purine metabolism, deafness and neurodevelopmental abnormality","volume":"16","author":"Simmonds","year":"1985","journal-title":"Neuropediatrics."},{"issue":"3","key":"10.1016\/j.metabol.2021.154841_bb0150","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0002-9343(88)90591-8","article-title":"Inherited superactivity of phosphoribosylpyrophosphate synthetase: association of uric acid overproduction and sensorineural deafness","volume":"85","author":"Becker","year":"1988","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.metabol.2021.154841_bb0155","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/10372","article-title":"Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness","volume":"22","author":"Labay","year":"1999","journal-title":"Nat Genet"},{"issue":"23","key":"10.1016\/j.metabol.2021.154841_bb0160","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1093\/hmg\/11.23.2951","article-title":"Targeted disruption of Slc19a2, the gene encoding the high-affinity thiamin transporter Thtr-1, causes diabetes mellitus, sensorineural deafness and megaloblastosis in mice","volume":"11","author":"Oishi","year":"2002","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.metabol.2021.154841_bb0165","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/ajmg.a.20506","article-title":"Novel mutation in the SLC19A2 gene in an African-American female with thiamine-responsive megaloblastic anemia syndrome","volume":"125A","author":"Lagarde","year":"2004","journal-title":"Am J Med Genet A"},{"issue":"1","key":"10.1016\/j.metabol.2021.154841_bb0170","first-page":"99","article-title":"Thiamine-responsive megaloblastic anaemia syndrome: long-term follow-up and mutation analysis of seven families","volume":"95","author":"Ricketts","year":"2006","journal-title":"Acta Paediatr Oslo Nor 1992"},{"key":"10.1016\/j.metabol.2021.154841_bb0175","first-page":"116","article-title":"Hereditary myoclonus and progressive muscular atrophy: a new syndrome","volume":"103","author":"Jankovic","year":"1978","journal-title":"Trans Am Neurol Assoc"},{"issue":"12","key":"10.1016\/j.metabol.2021.154841_bb0180","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.nmd.2015.09.007","article-title":"Acid ceramidase deficiency associated with spinal muscular atrophy with progressive myoclonic epilepsy","volume":"25","author":"Gan","year":"2015","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.metabol.2021.154841_bb0185","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13023-017-0585-5","article-title":"Possible mechanisms for sensorineural hearing loss and deafness in patients with propionic acidemia","volume":"12","author":"Gr\u00fcnert","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"10.1016\/j.metabol.2021.154841_bb0190","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ajhg.2010.08.002","article-title":"Mutations in ABHD12 cause the neurodegenerative disease PHARC: an inborn error of endocannabinoid metabolism","volume":"87","author":"Fiskerstrand","year":"2010","journal-title":"Am J Hum Genet"},{"issue":"12","key":"10.1016\/j.metabol.2021.154841_bb0195","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1002\/humu.22437","article-title":"Two novel mutations in ABHD12: expansion of the mutation spectrum in PHARC and assessment of their functional effects","volume":"34","author":"Chen","year":"2013","journal-title":"Hum Mutat"},{"issue":"2","key":"10.1016\/j.metabol.2021.154841_bb0200","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/jns.12367","article-title":"Genotype-phenotype correlation in a novel ABHD12 mutation underlying PHARC syndrome","volume":"25","author":"Thimm","year":"2020","journal-title":"J Peripher Nerv Syst"},{"issue":"3","key":"10.1016\/j.metabol.2021.154841_bb0205","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA."},{"issue":"Pt 1","key":"10.1016\/j.metabol.2021.154841_bb0210","first-page":"143","article-title":"Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease","volume":"130","author":"Ries","year":"2007","journal-title":"Brain J Neurol"},{"issue":"8","key":"10.1016\/j.metabol.2021.154841_bb0215","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1023\/B:BOLI.0000009948.86528.72","article-title":"Hearing loss in Fabry disease: the effect of agalsidase alfa replacement therapy","volume":"26","author":"Hajioff","year":"2003","journal-title":"J Inherit Metab Dis"},{"issue":"10","key":"10.1016\/j.metabol.2021.154841_bb0220","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s00415-007-0575-y","article-title":"Vestibular and auditory deficits in Fabry disease and their response to enzyme replacement therapy","volume":"254","author":"Palla","year":"2007","journal-title":"J Neurol"},{"issue":"6","key":"10.1016\/j.metabol.2021.154841_bb0225","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s10545-009-1290-x","article-title":"Ear symptoms in children with Fabry disease: data from the Fabry outcome survey","volume":"32","author":"Keilmann","year":"2009","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"10.1016\/j.metabol.2021.154841_bb0230","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10545-017-0051-5","article-title":"Hearing loss in children with Fabry disease","volume":"40","author":"Suntjens","year":"2017","journal-title":"J Inherit Metab Dis"},{"issue":"5 Pt 1","key":"10.1016\/j.metabol.2021.154841_bb0235","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/000348948909800509","article-title":"Otologic histopathology of Fabry\u2019s disease","volume":"98","author":"Schachern","year":"1989","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"4","key":"10.1016\/j.metabol.2021.154841_bb0240","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2215\/CJN.09480819","article-title":"The changing landscape of Fabry disease","volume":"15","author":"Svarstad","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.metabol.2021.154841_bb0245","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s10545-018-0147-6","article-title":"Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutations","volume":"41","author":"Chesher","year":"2018","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"10.1016\/j.metabol.2021.154841_bb0250","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000354661","article-title":"Hearing loss is part of the clinical picture of ENPP1 loss of function mutation","volume":"81","author":"Brachet","year":"2014","journal-title":"Horm Res Paediatr"},{"issue":"7","key":"10.1016\/j.metabol.2021.154841_bb0255","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41581-019-0152-5","article-title":"Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia","volume":"15","author":"Haffner","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1016\/j.metabol.2021.154841_bb0260","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.pcl.2018.09.004","article-title":"Hypophosphatemic rickets","volume":"66","author":"Bitzan","year":"2019","journal-title":"Pediatr Clin North Am"},{"issue":"1","key":"10.1016\/j.metabol.2021.154841_bb0265","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1017\/S0022215107001636","article-title":"Hearing loss and fluctuating hearing levels in X-linked hypophosphataemic osteomalacia","volume":"123","author":"Pantel","year":"2009","journal-title":"J Laryngol Otol"},{"issue":"2","key":"10.1016\/j.metabol.2021.154841_bb0270","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s13311-013-0177-6","article-title":"Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options","volume":"10","author":"El-Hattab","year":"2013","journal-title":"Neurotherapeutics."},{"issue":"Pt 3","key":"10.1016\/j.metabol.2021.154841_bb0275","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/brain\/awl389","article-title":"SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness","volume":"130","author":"Carrozzo","year":"2007","journal-title":"Brain J Neurol"},{"issue":"3","key":"10.1016\/j.metabol.2021.154841_bb0280","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ymgme.2016.11.005","article-title":"Succinyl-CoA synthetase (SUCLA2) deficiency in two siblings with impaired activity of other mitochondrial oxidative enzymes in skeletal muscle without mitochondrial DNA depletion","volume":"120","author":"Huang","year":"2017","journal-title":"Mol Genet Metab"},{"issue":"6","key":"10.1016\/j.metabol.2021.154841_bb0285","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/ana.410330613","article-title":"Phenotypic heterogeneity in families with the myoclonic epilepsy and ragged-red fiber disease point mutation in mitochondrial DNA","volume":"33","author":"Graf","year":"1993","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.metabol.2021.154841_bb0290","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00415-016-8086-3","article-title":"Expanded phenotypic spectrum of the m.8344A>G \u201cMERRF\u201d mutation: data from the German mitoNET registry","volume":"263","author":"Altmann","year":"2016","journal-title":"J Neurol"},{"issue":"9 Pt 1","key":"10.1016\/j.metabol.2021.154841_bb0295","doi-asserted-by":"crossref","first-page":"721","DOI":"10.7326\/0003-4819-134-9_Part_1-200105010-00008","article-title":"Maternally inherited diabetes and deafness: a multicenter study","volume":"134","author":"Guillausseau","year":"2001","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.metabol.2021.154841_bb0300","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1464-5491.2008.02359.x","article-title":"Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation","volume":"25","author":"Murphy","year":"2008","journal-title":"Diabet Med"},{"issue":"5","key":"10.1016\/j.metabol.2021.154841_bb0305","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s001250050950","article-title":"The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation","volume":"41","author":"Suzuki","year":"1998","journal-title":"Diabetologia."},{"issue":"2","key":"10.1016\/j.metabol.2021.154841_bb0310","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0960-8966(92)90045-8","article-title":"Melas: an original case and clinical criteria for diagnosis","volume":"2","author":"Hirano","year":"1992","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"10.1016\/j.metabol.2021.154841_bb0315","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.bbagen.2011.03.015","article-title":"MELAS: a nationwide prospective cohort study of 96 patients in Japan","volume":"1820","author":"Yatsuga","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.metabol.2021.154841_bb0320","doi-asserted-by":"crossref","first-page":"296","DOI":"10.5152\/iao.2019.5913","article-title":"Audiological and vestibular findings in subjects with MELAS syndrome","volume":"15","author":"Hougaard","year":"2019","journal-title":"J Int Adv Otol"},{"issue":"1","key":"10.1016\/j.metabol.2021.154841_bb0325","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13023-018-0770-1","article-title":"Hearing impairment in MELAS: new prospective in clinical use of microRNA, a systematic review","volume":"13","author":"Di Stadio","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"10.1016\/j.metabol.2021.154841_bb0330","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/ana.410430313","article-title":"Cochlear origin of hearing loss in MELAS syndrome","volume":"43","author":"Sue","year":"1998","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.metabol.2021.154841_bb0335","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1258\/0022215021910825","article-title":"Cochlear implantation in maternal inherited diabetes and deafness syndrome","volume":"116","author":"Raut","year":"2002","journal-title":"J Laryngol Otol"},{"issue":"1\u20132","key":"10.1016\/j.metabol.2021.154841_bb0340","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2015.06.004","article-title":"MELAS syndrome: clinical manifestations, pathogenesis, and treatment options","volume":"116","author":"El-Hattab","year":"2015","journal-title":"Mol Genet Metab"},{"issue":"4","key":"10.1016\/j.metabol.2021.154841_bb0345","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10162-014-0459-7","article-title":"Hearing loss is an early consequence of Npc1 gene deletion in the mouse model of Niemann-Pick disease, type C","volume":"15","author":"King","year":"2014","journal-title":"J Assoc Res Otolaryngol"},{"key":"10.1016\/j.metabol.2021.154841_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijporl.2015.11.009","article-title":"Otorhinolaryngological, audiovestibular and swallowing manifestations of patients with Niemann-Pick disease Type C","volume":"80","author":"Senirli","year":"2016","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"9","key":"10.1016\/j.metabol.2021.154841_bb0355","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(07)70194-1","article-title":"Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study","volume":"6","author":"Patterson","year":"2007","journal-title":"Lancet Neurol"},{"issue":"12","key":"10.1016\/j.metabol.2021.154841_bb0360","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3109\/14992027.2013.840932","article-title":"Prevalence of hearing loss in patients with late-onset Pompe disease: audiological and otological consequences","volume":"52","author":"Hanisch","year":"2013","journal-title":"Int J Audiol"},{"issue":"1","key":"10.1016\/j.metabol.2021.154841_bb0365","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.nbd.2003.12.018","article-title":"Hearing loss in infantile Pompe\u2019s disease and determination of underlying pathology in the knockout mouse","volume":"16","author":"Kamphoven","year":"2004","journal-title":"Neurobiol Dis"},{"issue":"5","key":"10.1016\/j.metabol.2021.154841_bb0370","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10545-010-9144-0","article-title":"Hearing loss in Pompe disease revisited: results from a study of 24 children","volume":"33","author":"van Capelle","year":"2010","journal-title":"J Inherit Metab Dis"},{"issue":"9","key":"10.1016\/j.metabol.2021.154841_bb0375","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/ajmg.a.61273","article-title":"Hearing impairment as an early sign of alpha-mannosidosis in children with a mild phenotype: report of seven new cases","volume":"179","author":"Lehalle","year":"2019","journal-title":"Am J Med Genet A"},{"issue":"1","key":"10.1016\/j.metabol.2021.154841_bb0380","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10545-013-9622-2","article-title":"The natural course and complications of alpha-mannosidosis--a retrospective and descriptive study","volume":"37","author":"Malm","year":"2014","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"10.1016\/j.metabol.2021.154841_bb0385","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1258\/00222150360600931","article-title":"Hearing loss due to mannosidosis and otitis media with effusion. A case report and review of audiological assessments in children with otitis media with effusion","volume":"117","author":"Ahmmed","year":"2003","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.metabol.2021.154841_bb0390","first-page":"19(5)","article-title":"Alpha-Mannosidosis: therapeutic strategies","volume":"17","author":"Ceccarini","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.metabol.2021.154841_bb0395","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jpeds.2004.01.025","article-title":"Effective treatment of alpha-mannosidosis by allogeneic hematopoietic stem cell transplantation","volume":"144","author":"Grewal","year":"2004","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.metabol.2021.154841_bb0400","doi-asserted-by":"crossref","DOI":"10.1101\/mcs.a003954","article-title":"\u03b2-Mannosidosis caused by a novel homozygous intragenic inverted duplication in MANBA","volume":"5","author":"Blomqvist","year":"2019","journal-title":"Cold Spring Harb Mol Case Stud"},{"issue":"1","key":"10.1016\/j.metabol.2021.154841_bb0405","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/archneur.63.1.129","article-title":"Atypical Gilles de la Tourette Syndrome with beta-mannosidase deficiency","volume":"63","author":"Sedel","year":"2006","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.metabol.2021.154841_bb0410","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ana.20702","article-title":"Clinical and biochemical spectrum of D-bifunctional protein deficiency","volume":"59","author":"Ferdinandusse","year":"2006","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.metabol.2021.154841_bb0415","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000114","article-title":"Heterozygous mutations in HSD17B4 cause juvenile peroxisomal D-bifunctional protein deficiency","volume":"2","author":"Amor","year":"2016","journal-title":"Neurol Genet"},{"issue":"6","key":"10.1016\/j.metabol.2021.154841_bb0420","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1210\/en.2012-1137","article-title":"The inflammatory response in acyl-CoA oxidase 1 deficiency (pseudoneonatal adrenoleukodystrophy)","volume":"153","author":"El Hajj","year":"2012","journal-title":"Endocrinology."},{"issue":"1","key":"10.1016\/j.metabol.2021.154841_bb0425","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1067\/mpd.2002.120511","article-title":"Peroxisomal acyl CoA oxidase deficiency","volume":"140","author":"Suzuki","year":"2002","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.metabol.2021.154841_bb0430","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1023\/B:BOLI.0000016687.88818.6d","article-title":"Straight-chain acyl-CoA oxidase deficiency presenting with dysmorphia, neurodevelopmental autistic-type regression and a selective pattern of leukodystrophy","volume":"27","author":"Kurian","year":"2004","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.metabol.2021.154841_bb0435","first-page":"511","article-title":"Adrenoleukodystrophy and Zellweger syndrome","volume":"321","author":"Moser","year":"1990","journal-title":"Prog Clin Biol Res"},{"issue":"12","key":"10.1016\/j.metabol.2021.154841_bb0440","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.bbamcr.2006.09.010","article-title":"Peroxisome biogenesis disorders","volume":"1763","author":"Steinberg","year":"2006","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.1016\/j.metabol.2021.154841_bb0445","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/ana.410440505","article-title":"Clinical approach to inherited peroxisomal disorders: a series of 27 patients","volume":"44","author":"Baumgartner","year":"1998","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.metabol.2021.154841_bb0450","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ajmg.a.20664","article-title":"Peroxisome biogenesis disorders with prolonged survival: phenotypic expression in a cohort of 31 patients","volume":"126A","author":"Poll-The","year":"2004","journal-title":"Am J Med Genet A"},{"issue":"8","key":"10.1016\/j.metabol.2021.154841_bb0455","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.ijporl.2015.05.023","article-title":"Audiological findings in Infantile Refsum disease","volume":"79","author":"Vandana","year":"2015","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"1","key":"10.1016\/j.metabol.2021.154841_bb0460","doi-asserted-by":"crossref","first-page":"a003483","DOI":"10.1101\/mcs.a003483","article-title":"A newly identified mutation in the PEX26 gene is associated with a milder form of Zellweger spectrum disorder","volume":"5","author":"Tanaka","year":"2019","journal-title":"Cold Spring Harb Mol Case Stud"},{"issue":"3","key":"10.1016\/j.metabol.2021.154841_bb0465","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ymgme.2015.12.009","article-title":"Peroxisome biogenesis disorders in the Zellweger spectrum: an overview of current diagnosis, clinical manifestations, and treatment guidelines","volume":"117","author":"Braverman","year":"2016","journal-title":"Mol Genet Metab"},{"issue":"9","key":"10.1016\/j.metabol.2021.154841_bb0470","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.bbadis.2009.08.005","article-title":"CDG nomenclature: time for a change!","volume":"1792","author":"Jaeken","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl. 1","key":"10.1016\/j.metabol.2021.154841_bb0475","doi-asserted-by":"crossref","first-page":"S335","DOI":"10.1007\/s10545-009-1297-3","article-title":"RFT1-CDG: deafness as a novel feature of congenital disorders of glycosylation","volume":"32","author":"Jaeken","year":"2009","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"10.1016\/j.metabol.2021.154841_bb0480","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s10038-018-0552-6","article-title":"Compound heterozygous variants in MOGS inducing congenital disorders of glycosylation (CDG) IIb","volume":"64","author":"Li","year":"2019","journal-title":"J Hum Genet"},{"key":"10.1016\/j.metabol.2021.154841_bb0485","first-page":"16","article-title":"ALG11-CDG: three novel mutations and further characterization of the phenotype","volume":"2","author":"Regal","year":"2015","journal-title":"Mol Genet Metab Rep"},{"issue":"1","key":"10.1016\/j.metabol.2021.154841_bb0490","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ajhg.2014.05.007","article-title":"PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasia","volume":"95","author":"Stray-Pedersen","year":"2014","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.metabol.2021.154841_bb0495","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1590\/1678-4685-gmb-2017-0172","article-title":"Large deletion in PIGL: a common mutational mechanism in CHIME syndrome?","volume":"41","author":"Ceroni","year":"2018","journal-title":"Genet Mol Biol"},{"issue":"8","key":"10.1016\/j.metabol.2021.154841_bb0500","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/jbmr.2834","article-title":"Spondyloocular syndrome: novel mutations in XYLT2 gene and expansion of the phenotypic spectrum","volume":"31","author":"Taylan","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"10","key":"10.1016\/j.metabol.2021.154841_bb0505","doi-asserted-by":"crossref","first-page":"e955","DOI":"10.1097\/MAO.0000000000002422","article-title":"Auditory characteristics in patients with mucopolysaccharidosis","volume":"40","author":"Ahn","year":"2019","journal-title":"Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol"},{"issue":"Suppl. 2","key":"10.1016\/j.metabol.2021.154841_bb0510","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13052-018-0555-0","article-title":"ENT and mucopolysaccharidoses","volume":"44","author":"Bianchi","year":"2018","journal-title":"Ital J Pediatr"},{"issue":"4","key":"10.1016\/j.metabol.2021.154841_bb0515","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ymgme.2014.02.003","article-title":"Assessment of hearing loss by pure-tone audiometry in patients with mucopolysaccharidoses","volume":"111","author":"Lin","year":"2014","journal-title":"Mol Genet Metab"},{"issue":"5","key":"10.1016\/j.metabol.2021.154841_bb0520","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.otorri.2016.11.004","article-title":"Audiological findings in children with mucopolysaccharidoses type i-iv","volume":"68","author":"Vargas-Gamarra","year":"2017","journal-title":"Acta Otorrinolaringol Esp"},{"issue":"4","key":"10.1016\/j.metabol.2021.154841_bb0525","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ymgme.2018.02.002","article-title":"Neurophysiology of hearing in patients with mucopolysaccharidosis type IV","volume":"123","author":"Nagao","year":"2018","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.metabol.2021.154841_bb0530","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1750-1172-5-5","article-title":"Mucopolysaccharidosis VI","volume":"5","author":"Valayannopoulos","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.metabol.2021.154841_bb0535","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.6061\/clinics\/2018\/e523","article-title":"Audiometric evaluation in individuals with mucopolysaccharidosis","volume":"73","author":"Silveira","year":"2018","journal-title":"Clin Sao Paulo Braz"},{"issue":"14","key":"10.1016\/j.metabol.2021.154841_bb0540","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199610033351405","article-title":"Clinical and biochemical manifestations of hyaluronidase deficiency","volume":"335","author":"Natowicz","year":"1996","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.metabol.2021.154841_bb0545","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.bjorl.2015.09.006","article-title":"The impact of laronidase treatment in otolaryngological manifestations of patients with mucopolysaccharidosis","volume":"82","author":"Dualibi","year":"2016","journal-title":"Braz J Otorhinolaryngol"},{"issue":"1\u20132","key":"10.1016\/j.metabol.2021.154841_bb0550","first-page":"1","article-title":"Lysosomal storage diseases","volume":"2","author":"Ferreira","year":"2017","journal-title":"Transl Sci Rare Dis"},{"issue":"7","key":"10.1016\/j.metabol.2021.154841_bb0555","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.clinph.2004.02.022","article-title":"Brain-stem auditory and visual evoked potentials in children with Krabbe disease","volume":"115","author":"Aldosari","year":"2004","journal-title":"Clin Neurophysiol"},{"issue":"2","key":"10.1016\/j.metabol.2021.154841_bb0560","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bbadis.2009.10.008","article-title":"Vacuolization and alterations of lysosomal membrane proteins in cochlear marginal cells contribute to hearing loss in neuraminidase 1-deficient mice","volume":"1802","author":"Wu","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2021.154841_bb0565","first-page":"8(2)","article-title":"Sialidosis: a review of morphology and molecular biology of a rare pediatric disorder","volume":"25","author":"Khan","year":"2018","journal-title":"Diagn Basel Switz"},{"key":"10.1016\/j.metabol.2021.154841_bb0570","first-page":"100561","article-title":"Sialidosis type II: expansion of phenotypic spectrum and identification of a common mutation in seven patients","volume":"22","author":"Arora","year":"2020","journal-title":"Mol Genet Metab Rep Mol Genet Metab Rep"},{"issue":"3","key":"10.1016\/j.metabol.2021.154841_bb0575","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0925-4439(94)90002-7","article-title":"The biochemistry and clinical features of galactosialidosis","volume":"1225","author":"Okamura-Oho","year":"1994","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.metabol.2021.154841_bb0580","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/jimd.12010","article-title":"Quantitative natural history characterization in a cohort of 142 published cases of patients with galactosialidosis-a cross-sectional study","volume":"42","author":"Sl\u00e1ma","year":"2019","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"10.1016\/j.metabol.2021.154841_bb0585","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/21678707.2016.1266933","article-title":"Galactosialidosis: historic aspects and overview of investigated and emerging treatment options","volume":"5","author":"Annunziata","year":"2017","journal-title":"Expert Opin Orphan Drugs"},{"issue":"5","key":"10.1016\/j.metabol.2021.154841_bb0590","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.bbamcr.2015.11.015","article-title":"Human disorders of peroxisome metabolism and biogenesis","volume":"1863","author":"Waterham","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.metabol.2021.154841_bb0595","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/1346-8138.13284","article-title":"Inherited ichthyosis: syndromic forms","volume":"43","author":"Yoneda","year":"2016","journal-title":"J Dermatol"},{"key":"10.1016\/j.metabol.2021.154841_bb0600","series-title":"GeneReviews\u00ae [Internet]","article-title":"Refsum disease. 2006 Mar 20 [updated 2015 Jun 11]","author":"Wanders","year":"1993"},{"issue":"5","key":"10.1016\/j.metabol.2021.154841_bb0605","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.0022-3042.2002.00766.x","article-title":"Refsum\u2019s disease: a peroxisomal disorder affecting phytanic acid alpha-oxidation","volume":"80","author":"Wierzbicki","year":"2002","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.metabol.2021.154841_bb0610","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0165-5876(01)00559-6","article-title":"The site of the hearing loss in Refsum\u2019s disease","volume":"61","author":"Oysu","year":"2001","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"3","key":"10.1016\/j.metabol.2021.154841_bb0615","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1046\/j.1365-2273.2003.00694.x","article-title":"Hearing loss in adult Refsum\u2019s disease","volume":"28","author":"Bamiou","year":"2003","journal-title":"Clin Otolaryngol Allied Sci"},{"issue":"8","key":"10.1016\/j.metabol.2021.154841_bb0620","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1177\/0003489417717269","article-title":"Cochlear implantation in siblings with Refsum\u2019s disease","volume":"126","author":"St\u00e4hr","year":"2017","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"2","key":"10.1016\/j.metabol.2021.154841_bb0625","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1179\/cim.2008.9.2.97","article-title":"Cochlear implantation in Refsum\u2019s disease","volume":"9","author":"Raine","year":"2008","journal-title":"Cochlear Implants Int"},{"issue":"1","key":"10.1016\/j.metabol.2021.154841_bb0630","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1097\/MAO.0000000000002063","article-title":"Cochlear implantation in Refsum disease with facial nerve enlargement","volume":"40","author":"Horoi","year":"2019","journal-title":"Otol Neurotol"},{"issue":"6","key":"10.1016\/j.metabol.2021.154841_bb0635","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1177\/0003489414526846","article-title":"Refsum\u2019s disease and cochlear implantation","volume":"123","author":"Nogueira","year":"2014","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"8562","key":"10.1016\/j.metabol.2021.154841_bb0640","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0140-6736(87)92542-6","article-title":"Lysosomal alpha-N-acetylgalactosaminidase deficiency: a new inherited metabolic disease","volume":"2","author":"van Diggelen","year":"1987","journal-title":"Lancet."},{"issue":"2","key":"10.1016\/j.metabol.2021.154841_bb0645","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1172\/JCI115357","article-title":"Lysosomal alpha-N-acetylgalactosaminidase deficiency, the enzymatic defect in angiokeratoma corporis diffusum with glycopeptiduria","volume":"88","author":"Kanzaki","year":"1991","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.metabol.2021.154841_bb0650","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI114901","article-title":"Schindler disease: the molecular lesion in the alpha-N-acetylgalactosaminidase gene that causes an infantile neuroaxonal dystrophy","volume":"86","author":"Wang","year":"1990","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.metabol.2021.154841_bb0655","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/BF00712015","article-title":"Mild phenotypic expression of alpha-N-acetylgalactosaminidase deficiency in two adult siblings","volume":"17","author":"Chab\u00e1s","year":"1994","journal-title":"J Inherit Metab Dis"},{"issue":"9","key":"10.1016\/j.metabol.2021.154841_bb0660","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1212\/01.WNL.0000123116.96441.34","article-title":"Neurologic manifestations of Kanzaki disease","volume":"62","author":"Umehara","year":"2004","journal-title":"Neurology."},{"issue":"2","key":"10.1016\/j.metabol.2021.154841_bb0665","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1365-2133.2001.04028.x","article-title":"A new case of alpha-N-acetylgalactosaminidase deficiency with angiokeratoma corporis diffusum, with M\u00e9ni\u00e8re\u2019s syndrome and without mental retardation","volume":"144","author":"Kodama","year":"2001","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.metabol.2021.154841_bb0670","article-title":"A new case of Schindler disease","volume":"6","author":"Castro","year":"2019","journal-title":"Eur J Case Rep Intern Med"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049521001414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049521001414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:27:56Z","timestamp":1758428876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049521001414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":134,"alternative-id":["S0026049521001414"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2021.154841","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hearing loss in inherited metabolic disorders: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2021.154841","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154841"}}